Stem Cells Cure Brain Disorder In A Trial
Researchers improve brain disorder survival rates in mice by injecting glial progenitor cells.
A team of researchers from University of Rochester Medical Center in New York examined mice with myelin-deficiency disorder and suggested that these mice can benefit from human neural stem cells - glial progenitor cells (GPCs). The cells were taken from human fetuses and then injected into mice brain.
GPCs injection managed to remyelinize demyelinated neurons. Myelin is a structure summarizing protein and fat, which surrounds long neuronal fibers - axons. Axons are sources for conscious and unconscious neural impulses. In other words, mylein is protecting axons and ensuring that nerve impulses can travel through entire nervous system safely.
Myelin damage causes various neurological disorders, such as multiple sclerosis. Myelin itself is being formed by oligodendrocytes cells, which are derived from GPCs. This is why researchers decided to study GPCs' affect on brain disorder.
Researchers examined mice with myelin shortage - called 'shiverer' -